Current Issue - March 2024, Volume 18, Issue No. 1

1. Izakovicova P, Borens O, Trampuz A. Periprosthetic joint infection: current concepts and outlook. EFORT Open Rev. 2019; 4(7): 482-94. doi: 10.1302/2058-5241.4.180092
2. Fiore M, Sambri A, Zucchini R, Giannini C, Donati DM, De Paolis M. Silver-coated megaprosthesis in prevention and treatment of peri-prosthetic infections: a systematic review and meta-analysis about efficacy and toxicity in primary and revision surgery. Eur J Orthop Surg Traumatol. 2021; 31(2): 201-20. doi: 10.1007/s00590-020-02779-z
3. Lex JR, Koucheki R, Stavropoulos NA, Michele JD, Toor JS, et al. Megaprosthesis anti-bacterial coatings: A comprehensive translational review. Acta Biomater. 2022; 140: 136-48. doi: 10.1016/j.actbio.2021.11.045
4. Hashimoto K, Nishimura S, Shinyashiki Y, Ito T, Kakinoki R, Akagi M. Novel reconstruction method by mega-prosthesis wrapped with vancomycin-containing cement after resection of malignancies. Medicine (Baltimore). 2022; 101(48): e31547. doi: 10.1097/MD.0000000000031547
5. Cheng H, Chen BP, Soleas IM, Ferko NC, Cameron CG, Hinoul P. Prolonged Operative Duration Increases Risk of Surgical Site Infections: A Systematic Review. Surg Infect (Larchmt). 2017; 18(6): 722-35. doi: 10.1089/sur.2017.089
6. Khakzad T, Karczewski D, Thielscher L, Reiter K, Wittenberg S, Paksoy A, et al. Prosthetic Joint Infection in Mega-Arthroplasty Following Shoulder, Hip and Knee Malignancy-A Prospective Follow-Up Study. Life (Basel). 2022; 12(12): 2134. doi: 10.3390/life12122134
7. Vento S, Cainelli F. Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment. Lancet Oncol. 2003; 4(10): 595-604. doi: 10.1016/s1470-2045(03)01218-x
8. Muller D, Kaiser D, Sairanen K, Studhalter T, Uckay I. Antimicrobial Prophylaxis for the Prevention of Surgical Site Infections in Orthopaedic Oncology - A Narrative Review of Current Concepts. J Bone Jt Infect. 2019; 4(6): 254-63. doi: 10.7150/jbji.39050
9. Schmidt-Braekling T, Streitbuerger A, Gosheger G, Boettner F, Nottrott M, Ahrens H, et al. Silver-coated megaprostheses: review of the literature. Eur J Orthop Surg Traumatol. 2017; 27(4): 483-9. doi: 10.1007/s00590-017-1933-9
10. Diez-Escudero A, Hailer NP. The role of silver coating for arthroplasty components. Bone Joint J. 2021; 103-B(3): 423-9. doi: 10.1302/0301-620X.103B3.BJJ-2020-1370.R1
11. Scoccianti G, Frenos F, Beltrami G, Campanacci DA, Capanna R. Levels of silver ions in body fluids and clinical results in silver-coated megaprostheses after tumour, trauma or failed arthroplasty. Injury. 2016; 47 Suppl 4: S11-6. doi: 10.1016/j.injury.2016.07.042
12. Bistolfi A, Massazza G, Verne E, Masse A, Deledda D, Ferraris S, et al. Antibiotic-loaded cement in orthopedic surgery: a review. ISRN Orthop. 2011; 2011: 290851. doi: 10.5402/2011/290851
13. Zoccali C, Scoccianti G, Biagini R, Daolio PA, Giardina FL, Campanacci DA. Antibacterial hydrogel coating in joint mega-prosthesis: results of a comparative series. Eur J Orthop Surg Traumatol. 2021; 31(8): 1647-55. doi: 10.1007/s00590-021-02884-7
14. Peng Z, Lin X, Kuang X, Teng Z, Lu S. The application of topical vancomycin powder for the prevention of surgical site infections in primary total hip and knee arthroplasty: A meta-analysis. Orthop Traumatol Surg Res. 2021; 107(4): 102741. doi: 10.1016/j.otsr.2020.09.006
15. Luo H, Ren Y, Su Y, Xue F, Hong Z. Intraoperative vancomycin powder to reduce surgical site infections after posterior spine surgery: a systematic review and meta-analysis. EFORT Open Rev. 2022; 7(2): 109-21. doi: 10.1530/EOR-21-0077
16. Campanacci DA, Totti F, Puccini S, Beltrami G, Scoccianti G, Delcroix L, et al. Intercalary reconstruction of femur after tumour resection: is a vascularized fibular autograft plus allograft a long-lasting solution? Bone Joint J. 2018; 100-B(3): 378-86. doi: 10.1302/0301-620X.100B3.BJJ-2017-0283.R2
17. Capanna R, Scoccianti G, Frenos F, Vilardi A, Beltrami G, Campanacci DA. What was the survival of megaprostheses in lower limb reconstructions after tumor resections? Clin Orthop Relat Res. 2015; 473(3): 820-30. doi: 10.1007/s11999-014-3736-1
18. Youssef B, Pavlou G, Tsiridis E. Philadelphia 2013: international consensus meeting on periprosthetic joint infection. Hip Int. 2014; 24(1): 3-4. doi: 10.5301/hipint.5000127
19. Gronchi A, Miah AB, Dei Tos AP, Abecassis N, Bajpai J, Bauer S, et al. Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆. Ann Oncol. 2021; 32(11): 1348-65. doi: 10.1016/j.annonc.2021.07.006
20. Casali PG, Bielack S, Abecassis N, Aro HT, Bauer S, Biagini R, et al. Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018; 29(Suppl 4): iv79-iv95. doi: 10.1093/annonc/mdy310
21. Zebala LP, Chuntarapas T, Kelly MP, Talcott M, Greco S, Riew KD. Intrawound vancomycin powder eradicates surgical wound contamination: an in vivo rabbit study. J Bone Joint Surg Am. 2014; 96(1): 46-51. doi: 10.2106/JBJS.L.01257
22. Wong MT, Sridharan SS, Davison EM, Ng R, Desy NM. Can Topical Vancomycin Prevent Periprosthetic Joint Infection in Hip and Knee Arthroplasty? A Systematic Review. Clin Orthop Relat Res. 2021; 479(8): 1655-64. doi: 10.1097/CORR.0000000000001777
23. Sweet FA, Roh M, Sliva C. Intrawound application of vancomycin for prophylaxis in instrumented thoracolumbar fusions: efficacy, drug levels, and patient outcomes. Spine (Phila Pa 1976). 2011; 36(24): 2084-8. doi: 10.1097/BRS.0b013e3181ff2cb1
24. Patel NN, Guild GN 3rd, Kumar AR. Intrawound vancomycin in primary hip and knee arthroplasty: a safe and cost-effective means to decrease early periprosthetic joint infection. Arthroplast Today. 2018; 4(4): 479-83. doi: 10.1016/j.artd.2018.07.011
25. Liao S, Yang Z, Li X, Chen J, Liu JG. Effects of different doses of vancomycin powder in total knee and hip arthroplasty on the periprosthetic joint infection rate: a systematic review and meta-analysis. J Orthop Surg Res. 2022; 17(1): 546. doi: 10.1186/s13018-022-03445-2
26. Matziolis G, Brodt S, Bohle S, Kirschberg J, Jacob B, Rohner E. Intraarticular vancomycin powder is effective in preventing infections following total hip and knee arthroplasty. Sci Rep. 2020; 10: 13053. doi: 10.1038/s41598-020-69958-0
27. Xu X, Zhang X, Zhang Y, Chen C, Yu H, Xue E. Role of intra-wound powdered vancomycin in primary total knee arthroplasty. Orthop Traumatol Surg Res. 2020; 106(3): 417-20. doi: 10.1016/j.otsr.2020.01.007
28. Otte JE, Politi JR, Chambers B, Smith CA. Intrawound Vancomycin Powder Reduces Early Prosthetic Joint Infections in Revision Hip and Knee Arthroplasty. Surg Technol Int. 2017; 30: 284-9.
29. Tahmasebi MN, Vaziri AS, Vosoughi F, Tahami M, Khalilizad M, Rabie H. Low post-arthroplasty infection rate is possible in developing countries: long-term experience of local vancomycin use in Iran. J Orthop Surg Res. 2021; 16(1): 199. doi: 10.1186/s13018-021-02344-2
30. Winkler C, Dennison J, Wooldridge A, Larumbe E, Caroom C, Jenkins M, et al. Do local antibiotics reduce periprosthetic joint infections? A retrospective review of 744 cases. J Clin Orthop Trauma. 2018; 9(Suppl 1): S34-9. doi: 10.1016/j.jcot.2017.08.007
31. Buchalter DB, Teo GM, Kirby DJ, Schwarzkopf R, Aggarwal VK, Long WJ. Does the Organism Profile of Periprosthetic Joint Infections Change With a Topical Vancomycin Powder and Dilute Povidone-Iodine Lavage Protocol? J Arthroplasty. 2021; 36(7S): S314-9. doi: 10.1016/j.arth.2020.12.036
32. Ducharme MP, Slaughter RL, Edwards DJ. Vancomycin pharmacokinetics in a patient population: effect of age, gender, and body weight. Ther Drug Monit. 1994; 16(5): 513-8. doi: 10.1097/00007691-199410000-00013

Abstract   |   Reference